Research graph
References from A Weighted Estimation Approach to Correct for Imperfect Mutation Detection Due to Intra-tumor Heterogeneity in Tumor Sequencing. Local targets link to admitted publications; unresolved targets remain external evidence.
Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers
10.1186/s13073-017-0425-1 · 2017 · External reference
10.1201/9781420010138
10.1201/9781420010138 · External reference
Resource-efficient pooled sequencing expands translational impact in solid tumors
2021 · External reference
Recurrent somatic mutations as predictors of immunotherapy response
10.1038/s41467-022-31055-3 · 2022 · External reference
10.1038/ng.2891
10.1038/ng.2891 · External reference
Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network
10.1158/1078-0432.ccr-12-3886 · 2013 · External reference
10.1056/nejmoa1616288
10.1056/nejmoa1616288 · External reference
10.1016/j.cell.2013.01.019
10.1016/j.cell.2013.01.019 · External reference
10.1002/sim.6164
10.1002/sim.6164 · External reference
10.1038/s41392-024-02004-x
10.1038/s41392-024-02004-x · External reference
10.1093/oxfordjournals.aje.a009251
10.1093/oxfordjournals.aje.a009251 · External reference
10.1016/j.cell.2017.01.018
10.1016/j.cell.2017.01.018 · External reference
10.18632/oncotarget.7067
10.18632/oncotarget.7067 · External reference
10.1093/biomet/86.4.843
10.1093/biomet/86.4.843 · External reference
Currently favored sampling practices for tumor sequencing can produce optimal results in the clinical setting
10.1038/s41598-020-71382-3 · 2020 · External reference
10.1038/s41576-019-0114-6
10.1038/s41576-019-0114-6 · External reference
BRAF and NRAS Mutation Status and Response to Checkpoint Inhibition in Advanced Melanoma
2022 · External reference
10.1038/s41591-021-01233-9
10.1038/s41591-021-01233-9 · External reference
